|
HS Code |
648233 |
| chemical_name | Trehalose Sulfate |
| molecular_formula | C12H24O16S |
| molecular_weight | 464.36 g/mol |
| appearance | White powder |
| solubility | Highly soluble in water |
| function | Bioprotectant and stabilizer |
| CAS_number | 107295-20-7 |
| storage_conditions | Store in a cool, dry place |
| stability | Stable under normal conditions |
| usage | Cosmetics, pharmaceuticals, research |
| odor | Odorless |
| pH | Neutral in aqueous solution |
| hazard_status | Non-hazardous |
| synonyms | Trehalose-6-sulfate |
As an accredited Trehalose Sulfate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Trehalose Sulfate is packaged in a 100g amber glass bottle, sealed, clearly labeled with hazard symbols and storage instructions. |
| Shipping | Trehalose Sulfate should be shipped in tightly sealed containers to prevent moisture absorption and contamination. Store and transport in cool, dry conditions, away from direct sunlight and incompatible materials. Follow all relevant safety regulations, including proper labeling and documentation, to ensure safe and compliant handling during transit. |
| Storage | Trehalose sulfate should be stored in a tightly closed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, ideally at room temperature (15–25°C/59–77°F). Avoid exposure to incompatible substances and sources of ignition. Proper labeling and adherence to local regulations are recommended for safe storage and handling of this chemical. |
| Purity 98%: Trehalose Sulfate with 98% purity is used in pharmaceutical formulations, where it enhances stability and solubility of active ingredients. Molecular Weight 400 Da: Trehalose Sulfate of molecular weight 400 Da is used in cosmetic serums, where it improves moisture retention and film formation. Stability Temperature 120°C: Trehalose Sulfate stable at 120°C is used in lyophilized vaccines, where it preserves protein integrity during high-temperature processing. Particle Size 20 µm: Trehalose Sulfate with 20 µm particle size is used in tablet manufacturing, where it ensures uniform dispersion and compressibility. Aqueous Solubility 150 g/L: Trehalose Sulfate with aqueous solubility of 150 g/L is used in injectable drug solutions, where it provides high concentration and clear formulation. Viscosity Grade Low: Trehalose Sulfate of low viscosity grade is used in beverage stabilization, where it minimizes changes to mouthfeel and pouring consistency. Optical Clarity ≥98%: Trehalose Sulfate with optical clarity ≥98% is used in ophthalmic solutions, where it maintains transparency and minimizes visual distortion. Melting Point 210°C: Trehalose Sulfate with a melting point of 210°C is used in hot-melt extrusion of nutritional supplements, where it enables thermal processing without decomposition. Endotoxin Level <0.1 EU/mg: Trehalose Sulfate with endotoxin level below 0.1 EU/mg is used in cell culture media, where it reduces risks of contamination and supports cell viability. pH Stability Range 4–8: Trehalose Sulfate stable within pH range 4–8 is used in buffer systems, where it maintains efficacy across various physiological conditions. |
Competitive Trehalose Sulfate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of specialty sugars, Trehalose Sulfate stands out for more than its name. Every day in our plant, we see customers from biotech, pharmaceuticals, and advanced materials sectors seeking a sugar derivative that offers more than the basic properties of standard trehalose. What these customers have in common: they’re tackling instability issues in enzymes, sensitive proteins, and vaccine formulations. They come looking for a product that brings resilience and reliability under stress without inviting unwanted side reactions.
Looking back on our development timeline, Trehalose Sulfate grew from hands-on trials in bioprocessing environments. Native trehalose, a naturally occurring disaccharide, showed its worth early on as a stabilizing agent for biological macromolecules. The sulfate modification brought a clear leap forward in specific stability and functionality. By adding sulfate groups, the molecule gains increased water solubility, higher ionic character, and notable compatibility with charged protein domains. Unlike unmodified trehalose, our sulfate variant copes with wider pH ranges and retains material integrity in complex buffers—traits not often found together in other disaccharide derivatives.
The main demand from innovators—whether in research or full-scale manufacturing—remains the same: “We need every kilo to behave just like the last.” Our facility answers this need through rigorous process controls that start with the initial batch synthesis. Our proprietary method blends trehalose in anhydrous conditions before sulfation, controlling reaction rates and avoiding byproduct contamination.
Process engineers carefully monitor the degree of substitution (DS). This isn’t a spec sheet number—it’s a daily operational reality that determines how Trehalose Sulfate performs in the final application. By controlling the DS, we offer variants spanning 1.8 to 2.3 sulfate groups per disaccharide. For pharmaceutical fills, most demand leans toward a 2.1 DS, which balances solubility and protein-protective effect without tipping into excessive ionic strength. Biotech teams working on high-shear mixing or lyophilization projects have gravitated toward the upper DS range, where stabilization against thermal and freeze-thaw shock matters.
Unlike ordinary trehalose powders, our sulfate variant resists caramelization and Maillard reactions. This stability opens doors for medical device coatings and injectable solutions—anywhere trace contaminants and unwanted browning would disrupt process validation or product registration. Years ago, a vaccine enterprise faced recurring yellowing problems during protein conjugate scale-up. Standard sugars failed to address it, so they integrated our sulfate variant at a pilot stage. Batch after batch, the product passed all color and clarity endpoints. Hard data came from HPLC monitoring: no measurable byproduct peaks, consistent light transmission across visible wavelengths.
Day in, day out, practical handling matters just as much as chemical structure. Trehalose Sulfate’s slightly hygroscopic, free-flowing powder form comes straight off our drying belts, packed under nitrogen since atmospheric moisture will invite caking if ignored. Warehouse staff tell us the extra nitrogen step shaves precious minutes off each transfer, and QC analysts see cleaner readings from the first sample pulled each shift. Our batches average 99% purity, based on non-reducing sugar assays and ICP-MS screening for leftover reagents.
Solubility outpaces that of unmodified trehalose, with rapid dissolution at ambient and refrigerated conditions. Centrifugation rarely leaves undissolved residues, saving time across prep lines. In buffers, the sulfate moiety acts as a gentle ionic counterpart, meaning complex formulations remain stable through repeated reconstitution cycles.
Every kilogram leaves our site traceable through layered barcoding and automated batch record archiving. This isn’t marketing—years of regulatory audits pushed us to hardwire traceability down to the starting material lot and operator ID. Teams running cGMP projects no longer face guessing games if a question arises during product release.
Biologics manufacturers were early adopters of Trehalose Sulfate. Consider a case from a monoclonal antibody facility: Trehalose Sulfate replaced a conventional stabilizer, yielding tighter batch-to-batch potency and eliminating the sporadic protein precipitation events that plagued the old process. After six months, yield loss in the fill-finish segment dropped under one percent—a change that affected bottom-line revenue and product reliability audits.
The benefits also reach out to the world of gene and cell therapy, where sensitive constructs like viral vectors and CRISPR payloads challenge standard excipients. Scientists on those lines confirmed that the sulfate derivative finishes strong under stress tests, supporting high titers and intact protein folding after freeze-drying. Our product maintained viral vector activity at two-year storage points, validated by third-party labs tracking qPCR and infectivity endpoints.
Recently, a specialty manufacturer of ophthalmic formulations tested Trehalose Sulfate in artificial tear development. Many trehalose variants interact unfavorably with polymeric excipients or form hazes at higher concentrations. Our sulfate form integrates smoothly, supporting transparent, isotonic solutions with shelf stability across wide temperature ranges. Years ago, such clarity was hard to achieve at viable cost and scale.
Looking at the market’s array of stabilizers—everything from glucose polymers to sucrose-based derivatives—one question matters: How will it perform under the customer’s real-word conditions, with all the operational complexities in play? In our own line, Trehalose Sulfate is regularly compared to maltose or lactose sulfates. Peers in those sectors report more unpredictable breakdown under high ionic loads and higher rates of protein aggregation.
Customers running diagnostic test lines with delicate antigens note fewer false negatives and stable calibration profiles with our product. It’s not an abstract difference but a tangible outcome, stemming from minimized chemical reactivity and superior retention of biological activity through accelerated aging trials.
We see fewer regulatory flags during product validation because our sulfate variant does not introduce reducing sugars. This point means no extra controls needed for potential glycation side-products, leaving customers with faster method development and lower risk in safety assessments. It saves time across technical transfer and helps teams focusing on global market registrations.
Running a chemical manufacturing site gives a close-up view of what traits truly set a product apart. At the granular level, purity alone means little unless it translates to reliable performance in industrial settings. Our Trehalose Sulfate earned its reputation in part because every team—production, quality, shipping—relies on streamlined procedures forged by decades of direct customer feedback. We maintain regular cycle reviews with formulation chemists and plant engineers, designing small batch runs to stress-test new applications and gather real operational data.
Production teams work with real-world variables: humidity swings, power fluctuations, raw material inconsistencies. Our internal control loops and robust risk management configurations aren’t spreadsheets, but on-the-floor protocols built over years of batch experience. Lab technicians at competitor sites sometimes report clumping and long dissolution times after air exposure—issues traced back to surface hydration kinetics linked to specific sulfate group arrangements. Our process counters these risks through careful pH adjustment and multi-stage drying, meaning end users see improved processability from first opening through the final dose formulated.
Every batch we ship gets tracked against predefined performance benchmarks drawn from routine stability and compatibility testing. In the rare event a customer flags a concern, QC pulls retain samples for side-by-side comparison, running NMR and FTIR to confirm structure and cross-check solubility curves. Over time, these return investigations have led us to tweak procedural controls, adjust final drying cycles, and introduce new packaging formats—always in response to actual operational feedback.
Years back, a clinical supply chain reported intermittent caking in tropical distribution zones. Our team worked overnight to pilot new packaging pouches with layered moisture and oxygen barriers, updating all outgoing orders within weeks. These supplier-driven modifications flow directly into our product—every improvement builds on cumulative experience and operational know-how.
Within stabilizers and cryoprotectants, options range from traditional sugars like sucrose and mannitol to more engineered forms such as hydroxyethyl starch or PEG derivatives. Trehalose Sulfate cuts a clearer profile for applications demanding both charge stabilization and protein integrity under harsh stressors.
Sucrose, still widely used in vaccine and enzyme storage, fails to hold protein structures through repeated freeze-thaw cycles. Mannitol, while a stable bulking agent, lacks the complex charge interactions of Trehalose Sulfate, often leading to aggregation in charged protein systems. Maltose and lactose sulfates compete on functionality, but exhibit higher breakdown under elevated temperatures and ionic stress.
Direct user trials in diagnostics, injectables, and cell therapies provide data showing tighter lot-to-lot consistency with Trehalose Sulfate. The product’s track record through real stability chambers, shelf-life studies, and accelerated aging far exceeds what we’ve seen from generic equivalents. Users across regions with changes in humidity and handling conditions consistently report more predictable powder handling and better end-product clarity.
Our mission isn’t just about synthesizing another specialty chemical. From the plant floor to the bench researcher prepping the next batch of clinical trial material, every kilogram of Trehalose Sulfate reflects a chain of decisions rooted in practical experience and direct feedback. Any new customer working toward higher stability, easier formulation, or fewer regulatory headaches will see benefits firsthand. Our biggest wins have surfaced from keeping open lines with formulation leaders, engineering continuous improvement into every production run, and keeping technical support grounded in what actually happens in the field.
As regulatory checkpoints sharpen and standards rise across biologics and diagnostics, Trehalose Sulfate continues to earn its place as a go-to stabilizer by delivering tangible, measured results. Our long-term collaborations with partners in gene therapy, vaccine development, and diagnostics push us to raise the bar every cycle, blending scientific innovation with the operational discipline forged by decades in specialty chemical production.
Moving through each season, new application boundaries get drawn by advances in biomedical technology and process engineering. As more therapies and diagnostic tools move from bench to bedside, the qualities we target in Trehalose Sulfate—high purity, reliable stabilization, compatibility across materials—grow in value. Some project partners now focus on ultra-long term storage or the unique demands of remote field deployment. For these teams, a sugar derivative that delivers stable, clean protein carriers at scale marks a genuine improvement in daily practice.
Instead of chasing trends, we take time to work inside customer production lines, capturing new hurdles and refining our process with every production lot. The end result is a Trehalose Sulfate product built to keep pace with the changing needs of life science pioneers, always backed by hands-on support and a plant-wide commitment to continuous improvement.
This ongoing progression—driven by field-level insights, not marketing slogans—shapes every kilogram we produce and every technical relationship we maintain. As the challenges in biology, pharmaceuticals, and diagnostics expand, so too does the operational depth behind every batch of Trehalose Sulfate shipped from our site.